Cytokinetics CYTK Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Product | |||||
| Collaboration Revenues | $8.69M+153% | $3.44M-14.7% | $4.03M-38.8% | $6.59M— | |
| License And Milestone Revenues | $79.35M+429% | $15M+329% | $3.5M+250% | $1M-98.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Cytokinetics break its business down?
- Cytokinetics (CYTK) reports revenue by product across 3 parts — Collaboration Revenues, License And Milestone Revenues and Net Product Revenue. Each is extracted from the segment footnotes and tracked over time.
- Where does Cytokinetics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Cytokinetics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
